Reckitt Benckiser Plc Fined $16.4 Million by U.K. Regulator Over Hearturn Drug Supplies to the National Health Service
Bloomberg -- Reckitt Benckiser Group Plc was fined 10.2 million pounds ($16.4 million) by a U.K. regulator for wrongfully stopping supplies of a heartburn medicine to the National Health Service after its patent expired.